- Novo Nordisk is suing Eli Lilly over ads it says mislead consumers on weight loss drug efficacy
Quartz
- Switching to Novo Nordisk's weight loss pill helped people keep shedding pounds
Quartz
- Novo Nordisk strikes second licensing deal since frosty capital-markets day
MarketWatch
- Novo Nordisk signed a $1.3 billion deal for technology to make longer-lasting obesity shots
Quartz
- U.S. demand for Novo Nordisk’s weight loss drugs is so huge that the Danish central bank just doubled the nation’s entire growth forecast
Fortune
- Novo Nordisk and Eli Lilly are being sued over weight loss drugs' link to vision loss
Quartz
- Novo Nordisk shares plunge over 7% as new targets fail to reassure investors
Yahoo Finance
- Novo Nordisk stock sinks after 2030 growth plan fails to impress investors
Quartz
- Novo Nordisk stock falls after 2030 strategy disappoints investors
Yahoo Finance
- Novo Nordisk stock gets drilled on pipeline concerns— its CEO sees this as the main problem
Yahoo Finance
- Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals
MarketWatch
- Novo Nordisk is partnering with Anthropic to speed up drug discovery using AI
QuartzBloomberg Technology
- Novo Nordisk rebrands as 'Novo', announces cultural reset
Yahoo Finance
- Novo Nordisk is rebranding as 'Novo' to fight Eli Lilly for obesity market share
Quartz
- Novo Nordisk rebrands as Novo to compete in obesity market
Yahoo Finance
- Novo Nordisk is seeking Chinese approval for its oral weight loss pill
Quartz
- Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak
MarketWatch